Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ELYM Eliem Therapeutics, Inc.	$109M	$0 100.0% of portfolio	0	Q1 2025 New
ENTA Enanta Pharmaceuticals Inc	$149M	$0 100.0% of portfolio	0	Q1 2025 New
ENLV Enlivex Therapeutics Ltd.	$17.3M	$0 100.0% of portfolio	0	Q1 2025 New
ENOB Enochian Biosciences Inc	$244M	$0 100.0% of portfolio	0	Q1 2025 New
ENTX Entera Bio Ltd.	$57.6M	$0 100.0% of portfolio	0	Q1 2025 New
TRDA Entrada Therapeutics, Inc.	$255M	$0 100.0% of portfolio	0	Q1 2025 New
EQ Equillium, Inc.	$12.7M	$0 100.0% of portfolio	0	Q1 2025 New
ERAS Erasca, Inc.	$192M	$0 100.0% of portfolio	0	Q1 2025 New
EPIX Essa Pharma Inc.	$75.4M	$0 100.0% of portfolio	0	Q1 2025 New
ETON Eton Pharmaceuticals, Inc.	$431M	$0 100.0% of portfolio	0	Q1 2025 New
EXEL Exelixis, Inc.	$13.6B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
EYPT Eye Point Pharmaceuticals, Inc.	$290M	$0 100.0% of portfolio	0	Q1 2025 New
FSTX F Star Therapeutics, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
FATE Fate Therapeutics Inc	$130M	$0 100.0% of portfolio	0	Q1 2025 New
FENC Fennec Pharmaceuticals Inc.	$214M	$0 100.0% of portfolio	0	Q1 2025 New
FGEN Fibrogen Inc	$29.1M	$0 100.0% of portfolio	0	Q1 2025 New
FWBI First Wave Bio Pharma, Inc.	$2.54M	$0 100.0% of portfolio	0	Q1 2025 New
FHTX Foghorn Therapeutics Inc.	$172M	$0 100.0% of portfolio	0	Q1 2025 New
FULC Fulcrum Therapeutics, Inc.	$376M	$0 100.0% of portfolio	0	Q1 2025 New
GANX Gain Therapeutics, Inc.	$23.9M	$0 100.0% of portfolio	0	Q1 2025 New
GLPG Galapagos Nv	$1.84B	$0 100.0% of portfolio	0	Q1 2025 New
GALT Galectin Therapeutics Inc	$76.7M	$0 100.0% of portfolio	0	Q1 2025 New
GNTA Genenta Science S.P.A.	$78.3M	$0 100.0% of portfolio	0	Q1 2025 New
GBIO Generation Bio Co.	$22.4M	$0 100.0% of portfolio	0	Q1 2025 New
GNFT Genfit S.A.	$210M	$0 100.0% of portfolio	0	Q1 2025 New
GMAB Genmab A/S	$14.4B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
GERN Geron Corp	$589M	$0 100.0% of portfolio	0	Q1 2025 New
GHRS Gh Research PLC	$656M	$0 100.0% of portfolio	0	Q1 2025 New
GLYC Glycomimetics Inc	$11M	$0 100.0% of portfolio	0	Q1 2025 New
GOSS Gossamer Bio, Inc.	$118M	$0 100.0% of portfolio	0	Q1 2025 New
GRAY Graybug Vision, Inc.	$63.5M	$0 100.0% of portfolio	0	Q1 2025 New
GLSI Greenwich Life Sciences, Inc.	$124M	$0 100.0% of portfolio	0	Q1 2025 New
HALO Halozyme Therapeutics, Inc.	$7.46B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
HRMY Harmony Biosciences Holdings, Inc.	$2.07B	$0 100.0% of portfolio	0	Q1 2025 New
HCWB Hcw Biologics Inc.	$238M	$0 100.0% of portfolio	0	Q1 2025 New
HRTX Heron Therapeutics, Inc.	$247M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
HLVX Hille Vax, Inc.	$65.5M	$0 100.0% of portfolio	0	Q1 2025 New
HUMA Humacyte, Inc.	$275M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
IMAB I Mab	$190M	$0 100.0% of portfolio	0	Q1 2025 New
IDYA Ideaya Biosciences, Inc.	$1.01B	$0 100.0% of portfolio	0	Q1 2025 New
IDRA Idera Pharmaceuticals, Inc.	$188M	$0 100.0% of portfolio	0	Q1 2025 New
IGMS Igm Biosciences, Inc.	$35.9M	$0 100.0% of portfolio	0	Q1 2025 New
IKNA Ikena Oncology, Inc.	$50.8M	$0 100.0% of portfolio	0	Q1 2025 New
IMGO Imago Bio Sciences, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
IMRA Imara Inc.	$552M	$0 100.0% of portfolio	0	Q1 2025 New
IMTX Immatics N.V.	$441M	$0 100.0% of portfolio	0	Q1 2025 New
IMMX Immix Biopharma, Inc.	$29.4M	$0 100.0% of portfolio	0	Q1 2025 New
ICCC Immucell Corp	$53.3M	$0 100.0% of portfolio	0	Q1 2025 New
IMRX Immuneering Corp	$49.4M	$0 100.0% of portfolio	0	Q1 2025 New
IMUX Immunic, Inc.	$21.7M	$0 100.0% of portfolio	0	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.